Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Analgesia Protocol in Head and Neck Cancer Surgery
NCT04176419Phase 3Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, Lidocaine Hydrochloride Injection, without epinephrine, acetaminophen, gabapentin and celecoxib oral solution in postoperative pain (2 arms), sponsored by Case Comprehensive Cancer Center. Primary endpoints: Total opioid consumption measured in daily morphine equivalent and Pain levels on Visual Analog Scale. Started Jan 2020; status: terminated.
02
Drugs
ketamineLidocaine Hydrochloride Injection, without epinephrineacetaminophengabapentincelecoxib oral solution
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04176419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176419.